NKF 202Alternative Names: NKF-202
Latest Information Update: 26 Nov 2015
At a glance
- Originator PUMC Pharmaceutical Company
- Class Vitamin D analogues
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Vitamin D deficiency
Most Recent Events
- 26 Nov 2015 Preregistration for Vitamin D deficiency in China (PO)